Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Eosinophilic Esophagitis Clinical Trials
Eosinophilic Esophagitis clinical trials are recruiting across 32 cities. Here are the cities with the most active studies:
Eosinophilic Esophagitis Trial Phases
12 research organizations are sponsoring eosinophilic esophagitis trials.
About Eosinophilic Esophagitis
Eosinophilic esophagitis (EoE) is a chronic allergic/immune condition where eosinophils accumulate in the esophagus, causing inflammation and difficulty swallowing. Prevalence has been increasing in recent decades. Treatment includes dietary elimination, proton pump inhibitors, and topical corticosteroids.
Clinical trials are advancing new treatments for eosinophilic esophagitis. Currently, 16 studies are recruiting a combined 18,056 participants across the United States. Research is being conducted by 12 organizations including National Institute of Allergy and Infectious Diseases (NIAID), Indiana University, University of California, San Diego and 9 others.
2026 Eosinophilic Esophagitis Research Landscape
As of July 2026, the eosinophilic esophagitis clinical trial landscape includes 16 actively recruiting studies across 32 cities in the United States. These studies are collectively seeking 18,056 participants, with an average enrollment target of 1,129 per study.
The research spans multiple phases of development: 3 studies are in NA, 2 studies are in PHASE3, 2 studies are in PHASE2, 1 study is in PHASE4. The presence of Phase 3 trials indicates that some eosinophilic esophagitis treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 12 different organizations, including National Institute of Allergy and Infectious Diseases (NIAID), Indiana University, University of California, San Diego, Ann & Robert H Lurie Children's Hospital of Chicago, Regeneron Pharmaceuticals, and 7 others. The large number of sponsors reflects significant research interest and investment in eosinophilic esophagitis treatment advancement.
Geographically, eosinophilic esophagitis trials are most concentrated in Bethesda, Maryland (3 trials); La Jolla, California (3 trials); Aurora, Colorado (3 trials); Indianapolis, Indiana (2 trials); San Diego, California (2 trials) and 7 other cities.
Featured Eosinophilic Esophagitis Studies
Highlighted recruiting studies for eosinophilic esophagitis, selected by enrollment size and research scope.
A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
Background: Allergic or sinus diseases can affect the skin, sinuses, airways, and other parts of the body. Examples include pollen and environmental allergies, food allergies, asthma, and eczema. To learn more about how to prevent and treat these diseases, researchers need to study data, blood, fluid, and tissue samples from people affected by them. Objective: To collect data, blood, fluid, and...
Indiana University Gastrointestinal Motility Diagnosis Registry
Develop a registry (list of patients) with accurate clinical motility diagnosis. This registry will help the doctors to identify the patients with specific disease conditions. It will also help in promoting future research in gastroenterology motility disorders
Characteristics and Inflammatory Markers in Children With Eosinophilic Esophagitis (EoE)
Single center observational and specimen banking study for children with eosinophilic esophagitis EoE to gauge natural history and inflammatory markers
Frequently Asked Questions About Eosinophilic Esophagitis Clinical Trials
Are there eosinophilic esophagitis clinical trials near me?
Yes, there are 16 eosinophilic esophagitis clinical trials currently recruiting across 32+ cities in the United States, including Bethesda, Maryland; La Jolla, California; Aurora, Colorado. Browse the studies above to find one at a location convenient for you.
How do I join a eosinophilic esophagitis clinical trial?
To join a eosinophilic esophagitis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are eosinophilic esophagitis clinical trials free?
Yes, participation in eosinophilic esophagitis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of eosinophilic esophagitis treatments are being studied?
Current eosinophilic esophagitis clinical trials are testing a range of approaches across NA (3 studies), PHASE3 (2 studies), PHASE2 (2 studies), PHASE4 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 12 research organizations.
Is it safe to participate in eosinophilic esophagitis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 14, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 14, 2026 · Data from ClinicalTrials.gov